Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Refractive Surgery/Lasik > Combining therapies improve post-LASIK dry eye symptoms
  • Refractive Surgery/Lasik

Combining therapies improve post-LASIK dry eye symptoms

Ophthalmology 360

Combining therapies such as intense pulsed light (IPL), heated eye mask (HEM), and 0.1% sodium hyaluronate (SH), may help improve the signs and symptoms of post-LASIK dry eye, according to a study.

In this study, 50 eyes of participants with persistent post-LASIK DE were treated with IPL and 0.1% SH (IPL group) and 50 eyes were treated with IPL in combination with 0.1% SH and HEM (IPL + group). The IPL+ group underwent 2 IPL sessions and daily HEM for 4 weeks while the IPL group underwent 2 IPL sessions. Both groups used daily 0.1% SH preservative-free eye drops.

All DE parameters evaluated in this study improved significantly at 4 weeks follow-up compared with baseline measurements.

At 4 weeks follow up, there were significant differences between IPL+group and the IPL group in their non-invasive tear break-up time, tear film lipid layer, lower tear meniscus height, meibomian gland quality, meibomian gland expressibility, and ocular surface disease index. No significant difference was noted between the groups in corneal fluorescein staining and artificial tear usage.

Reference
Wu Y, Xu L, Song Y, et al. Management of Post-LASIK Dry Eye with Intense Pulsed Light in Combination with 0.1% Sodium Hyaluronate and Heated Eye Mask. Ophthalmol Ther. 2021;doi: 10.1007/s40123-021-00418-2. Epub ahead of print. PMID: 34741758.

Share

Related Content

  • Refractive Surgery/Lasik

Zeiss MEL 90 excimer laser gains FDA approval

  • Refractive Surgery/Lasik

Ablation depth crucial in corneal sensitivity recovery within 3 months of LASEK

  • Exclusives

A Healthy Corneal Surface Helps Ensure Optimal Lasik Outcomes

  • Refractive Surgery/Lasik

The EVO Collamer Lens Transends Challenges of Earlier ICLs

  • Exclusives

Patient Selection for Presbyopia-Correcting Drops: Think Big

  • Glaucoma

The Ophthalmic Project: The Latest in Refractive Surgery

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon